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Accepted 26 March 2012; Published online 27 June 2012AbstractObjective: Meta-analysis of predictive values is usually discouraged because these values are directly affected by disease prevalence,
but sensitivity and specificity sometimes show substantial heterogeneity as well. We propose a bivariate random-effects logitnormal model
for the meta-analysis of the positive predictive value (PPV) and negative predictive value (NPV) of diagnostic tests.
Study Design and Setting: Twenty-three meta-analyses of diagnostic accuracy were reanalyzed. With separate models, we calculated
summary estimates of the PPV and NPV and summary estimates of sensitivity and specificity. We compared these summary estimates, the
goodness of fit of the two models, and the amount of heterogeneity of both approaches.
Results: There were no substantial differences in the goodness of fit or amount of heterogeneity between both models. The median
absolute difference between the projected PPV and NPV from the summary estimates of sensitivity and specificity and the summary esti-
mates of PPV and NPV was 1% point (interquartile range, 0e2% points).
Conclusion: A model for the meta-analysis of predictive values fitted the data from a range of systematic reviews equally well as meta-
analysis of sensitivity and specificity. The choice for either model could be guided by considerations of the design used in the primary
studies and sources of heterogeneity.
 2012 Elsevier Inc.
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Open access under the Elsevier OA license.1. Background
Current guidance for meta-analyses of diagnostic test
accuracy advocates the use of hierarchical methods to sum-
marize estimates of sensitivity and specificity or the diagnos-
tic odds ratio [1,2]. Sensitivity and specificity are not always
the most intuitive measures for clinicians, as they express at
the group level how many diseased and nondiseased were
correctly identified as such by the test. Clinicians may be
more familiar with predictive values [3,4]. The positive pre-
dictive value (PPV), for example, expresses the probability
of disease in those testing positive. Similarly, the negative* Corresponding author. Tel.: þ31-20-5666934; fax: þ31-20-6912683.
E-mail address: m.m.leeflang@amc.uva.nl (M.M.G. Leeflang).
0895-4356  2012 Elsevier Inc.
doi: 10.1016/j.jclinepi.2012.03.006
Open access under the Elsevier OA license.predictive value (NPV) expresses the probability of the
absence of disease in those testing negative.
For clinicians interested in predictive values, meta-
analyses of these statistics may be easier to understand
and to apply in practice. In addition, predictive values
may suffer less from work-up bias and problems associated
with partial and differential verification bias than sensitivity
and specificity [5]. In many studies, test positives are veri-
fied by a different clinical reference standard than test neg-
atives. Examples are accuracy studies where biopsy is the
reference standard; if no lesion is found, biopsy cannot be
done. In these studies, test negatives are either not verified
at all or clinically followed-up for verification of the nega-
tive test result. Different reference standards may also be
applied for ethical reasons, where one hesitates to use the
preferred but invasive reference standard in test negatives,
1089M.M.G. Leeflang et al. / Journal of Clinical Epidemiology 65 (2012) 1088e1097What is new?
 Current guidance for meta-analyses of diagnostic
test accuracy advocates the use of hierarchical
methods to summarize estimates of sensitivity
and specificity or the diagnostic odds ratio.
 We propose a model for direct meta-analysis of
predictive values, using similar hierarchical
methods.
 A model for the meta-analysis of predictive values
fitted the data from a range of systematic reviews
equally well as meta-analysis of sensitivity and
specificity.
 The choice for either model could be guided by
considerations about the designs used in the pri-
mary studies and likely sources of heterogeneity.
who have a lower probability of disease. Under these cir-
cumstances, summarizing predictive values may be more
meaningful than meta-analysis of sensitivity and specificity.
Meta-analysis of predictive values in systematic reviews
of test accuracy studies has been discouraged for several
reasons. Predictive values are expected to be more hetero-
geneous than other accuracy measures because they would
vary more directly with changes in disease prevalence. Sen-
sitivity and specificity, in contrast, are assumed to be more
stable characteristics of tests, which would make summary
estimates of sensitivity and specificity more meaningful.
The sources of variation and bias for sensitivity and speci-
ficity are better understood than those for predictive values.
Yet, one could successfully argue that these arguments are
too simple. Sensitivity and specificity are not fixed test
properties either. They describe the behavior of a test under
specific conditions, and they typically change across differ-
ent segments of the disease spectrum and with varying dis-
ease prevalence [6e8].
We propose a model for the meta-analysis of predictive
values, based on a previously published bivariate logitnor-
mal random-effects model for the meta-analysis of sensitiv-
ity and specificity.
If it is true that predictive values are more heterogeneous
than sensitivity and specificity, one can expect a lower
goodness of fit with a model for meta-analysis based on
predictive values. We therefore compared, across a range
of published systematic reviews, to what extent a model
for meta-analysis based on predictive values provides
a betterdor worsedsummary of the data than an equiva-
lent model based on sensitivity and specificity [9]. We also
compared the summary estimates from the model for pre-
dictive values with projected estimates from a meta-
analysis of sensitivity and specificity, using the median
prevalence and Bayes’ rule.2. Methods
2.1. Study set
We used a set of 31 meta-analyses, selected and analyzed
for a previously published report on bias and variation in di-
agnostic accuracy studies. The meta-analyses cover a wide
range of clinical topics and diagnostic tests, such as imaging
tests, laboratory tests, physical examination, and question-
naires. For more details on the search process, selection
and data-extraction, we refer to the original report [10]. In
short, a number of electronic databases were searched for
systematic reviews published between January 1999 and
April 2002 and fulfilling the following criteria: 1) assess-
ment of diagnostic test accuracy; 2) including at least 10
original studies on the same diagnostic test; 3) no exclusion
of primary studies based on design features; and 4) the abil-
ity to reproduce the 2  2 tables from the original studies.
We excluded caseecontrol studies to allow for realistic es-
timates of prevalence and predictive values.
2.2. Definitions
For every study, in each systematic review, we calculated
the PPVand NPV, and the sensitivity and specificity from the
reported numbers. The PPV was defined as the proportion of
patients with the target condition in those testing positive on
the test under evaluation. Similarly, the NPV was defined as
the proportion of patients without the target condition in
those testing negative on the test under evaluation. Conven-
tionally, sensitivity was defined as the proportion of patients
testing positive in those with the target condition. Specificity
was defined as the proportion of patients testing negative in
those without the target condition.
2.3. Descriptive statistics
We calculated the median, interquartile range (IQR), and
minimum and maximum predictive values, sensitivity, and
specificity of the studies in each review. We plotted these
descriptive statistics for PPV and NPV side by side to those
for sensitivity and specificity.
2.4. Meta-analysis
We developed a bivariate logitnormal random-effects
model for meta-analysis of predictive values. This model
has the same form as the previously proposed bivariate logi-
tnormalmodel formeta-analysis of sensitivity and specificity
[9]. That model was in itself based on an approach to meta-
analysis introduced by Van Houwelingen et al. [11,12].
The original bivariate model was used to obtain sum-
mary estimates of sensitivity and specificity for each test
in a review. In this model, pairs of sensitivity and specific-
ity are jointly analyzed, incorporating any correlation that
is to be expected between these two measures using a ran-
dom-effects approach. The correlation between sensitivity
and specificity will be mainly driven by threshold effects:
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sensitivity will be lower when the positivity threshold in-
creases, whereas specificity will be higher. Variability
within each individual study is assumed to be binomial, af-
fected by the number of patients and the study-specific sen-
sitivity and specificity. Across studies, sensitivity and
specificity for individual studies are assumed to follow a bi-
variate logitnormal distribution [9].
In the bivariate logitnormal random-effects model for pre-
dictive values, pairs of PPVand NPVare jointly analyzed, in-
corporating any correlation between these two measures
using a random-effects approach. The correlation between
PPV and NPV will be mainly driven by prevalence: when
prevalence increases, PPV will be higher, whereas NPV will
be lower. Here too, we assume that the true logit PPVand true
logit NPVof the individual studies are normally distributed
around a common mean (logitnormal distribution), but that
the true values may vary between studies (random-effects as-
sumption). The variability within each individual study is as-
sumed to be binomial, affected by the number of patients and
the study-specific PPVand NPV.
Data were analyzed in SAS for Windows, version 9.2
(Cary, NC), using the PROC NLMIXED procedure (see
Appendix). For every meta-analysis, the starting values
for the parameters were adapted, either based on graphs
plotting sensitivity by 1 specificity or PPV by 1NPV,
or on separate univariate analyses of each outcome.
2.5. Goodness of fit
We calculated Akaike’s Information Criterion (AIC) for
both bivariate models, in each application, as a measure of
goodness of fit of the models. We used the Wilcoxon
signed-rank test to evaluate a systematic difference in good-
ness of fit between the two approaches.
2.6. Heterogeneity
As heterogeneity in diagnostic accuracy studies can be
expressed in terms of the variance in logit sensitivity (or logit
PPV), variance in logit specificity (or logit NPV), and the
covariance between the two measures, we expressed hetero-
geneity as the area of the prediction ellipse around the sum-
mary point estimate of the mean in logit space. The
prediction ellipse is a two-dimensional representation of
the 95% prediction region around the logit sensitivity
(or PPV) and logit specificity (or NPV). The area of any
ellipse is calculated as:Area5a  b pwhere a and b are the minor and major axis of the ellipse
(see Fig. 1A). Derived from a bivariate logitnormal model,
the length of both axes depends on the variances of logit
sensitivity (or PPV) and logit specificity (or NPV), and
the correlation between the two. This can be expressed as the
eigen value, which corresponds to the variances adjustedfor correlation and follows from the varianceecovariance
matrix of the model. The square roots of the two eigen
values are the lengths of the minor and major axis a and
b (see also Fig. 1B).The areas for the two bivariate ap-
proaches were compared by computing the relative area
for each included meta-analysis. We used the Wilcoxon
signed-rank test to evaluate whether the area derived from
one approach was systematically smaller or larger than
the area derived from the other approach.
2.7. Derivation of predictive values from sensitivity and
specificity
From the summary estimates of sensitivity and specific-
ity, the natural logarithms of the corresponding positive and
negative likelihood ratios were estimated, their standard
errors, and hence confidence intervals being estimated
using the delta method. These estimates were then used
to calculate projected predictive values at the median prev-
alence in each review, using Bayes’ rule [3,4]:PPV5
post-test odds
ð1þ post-test oddsÞNPV51

post-test odds
ð1þ post-test oddsÞ
Post-test odds5

prevalence
ð1 prevalenceÞ

 likelihood ratio
Where the positive likelihood ratio is used to calculate
the PPV and the negative likelihood to calculate the NPV.
These results were compared with the summary estimates
from the predictive values model.3. Results
3.1. Descriptive statistics
Twenty-three meta-analyses fulfilled our criteria. They
contained 346 original studies in total, varying in sample
size from 10 to 20,381 patients (Table 1) [13e36]. The var-
iability in sensitivity, specificity, PPV, and NPV is shown in
Fig. 2. Mean prevalence varied between the reviews from
1% to 52%; the range in prevalence varied for each review
between 5% points (narrow prevalence range) to 78%
points (broad prevalence range) (see Fig. 3).
3.2. Goodness of fit
The random-effects model for predictive values con-
verged in all 23 cases. In 11 of the 23 reviews, the sensitiv-
ity/specificity model showed a better fit (lower AIC),
whereas in the 12 reviews, the predictive values model
showed a better fit (P5 0.83).
Fig. 1. Calculation of the surface area of an ellipse. A. General calculation. B. Example of 95% prediction ellipse for logit sensitivity and logit spec-
ificity. The dashed line is the shorter radius of the ellipse; the dotted line is the major radius of the ellipse.
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Heterogeneity was assessed by calculating the area of the
prediction ellipse around the point estimates (see Fig. 1).
The mean ratio of the areas for the models of sensitivity
and specificity vs. the predictive values approach varied
from 0.5 (i.e., area around predictive values was about twoTable 1. Characteristics of included meta-analysis
Author Topic
Mol [29] Ultrasound for Down Syndrome
Hoogendam [21] Digital rectal examination for prostate cancer
Lederle [27] Screening for abdominal aortic aneurysm
Huicho [22] Urine marker: dipstick nitrate
Sloan [32] Diagnosis of gonorrhea and chlamydial infections
Berger [15] Upper abdominal pain for gallstones
Lau [14]þBalk [13] Creatine kinase-myoglobin for acute myocardial inf
emergency department
Wiese [36] Wet mount slide for vaginal trichomoniasis
Fiellin [17] Questionnaires for lifetime alcohol dependence
Hurley [23] Limulus amebocyte lysate assay for diagnosis of Gr
infections
Visser [35] Ultrasound for peripheral arterial stenosis
Nelemans [30] Magnetic resonance angiography for peripheral arte
Kwok [26] Exercise electrocardiography for coronary artery dis
Hoffman [20] Workup of prostate cancer
Sonnad [33] Magnetic resonance imaging for staging of prostate
Mitchell [28] Pap smear for squamous intraepithelial lesions of t
Hobby [19] Diagnosis of tears of the triangular fibrocartilage co
Safriel [31] Spiral computed tomography for pulmonary emboli
Vasquez [34] Workup of acute cholecystitis
Kelly [24] Workup of staging in gastroesophageal carcinoma
Kim [25] Dobutamine stress echocardiography for coronary a
Gould [18] Positron emission tomography in the workup of pul
Deville [16] Workup of herniated discs in patients selected for s
First author and reference number, topic of the review, number of studies
of prevalence. The reviews are sorted by mean prevalence.
a Studies (range of included patients per study).times larger than around sensitivity and specificity) to
3.5 (i.e., area around sensitivity and specificity was 3.5 times
larger than around predictive values). In seven meta-
analyses, this area was larger for sensitivity and specificity
than for PPVand NPV. In 15 meta-analyses, it was the other
way around (see Fig. 4; P5 0.09). In one meta-analysis, theNa Prevalence (medianD range)
22 (99e20,381) 0.01 (0.00e0.05)
13 (309e6,630) 0.03 (0.01e0.07)
10 (21e424) 0.07 (0.01e0.17)
16 (23e3,251) 0.15 (0.01e0.30)
14 (172e1,222) 0.13 (0.03e0.37)
11 (83e1,896) 0.13 (0.05e0.41)
arction in the 19 (59e2,093) 0.22 (0.06e0.42)
29 (68e1,199) 0.26 (0.07e0.55)
12 (84e1,333) 0.28 (0.05e0.45)
am-negative 22 (10e218) 0.25 (0.10e0.68)
17 (12e167) 0.29 (0.05e0.72)
rial disease 13 (12e45) 0.41 (0.15e0.73)
ease in women 19 (33e613) 0.37 (0.18e0.62)
10 (29e673) 0.41 (0.22e0.76)
cancer 21 (18e235) 0.48 (0.23e0.82)
he cervix 17 (18e3,534) 0.43 (0.17e0.95)
mplex in the wrist 11 (13e102) 0.50 (0.39e0.94)
10 (20e149) 0.46 (0.27e0.82)
15 (20e163) 0.47 (0.10e0.72)
13 (13e328) 0.60 (0.23e0.85)
rtery disease 39 (27e288) 0.72 (0.29e0.87)
monary nodules 29 (17e109) 0.70 (0.50e0.96)
urgery 11 (52e2,504) 0.77 (0.56e0.98)
and range of number of participants per study, and median and range
Fig. 2. Raw results for sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). Reviews are in alphabetical
order. Each bubble represents a single primary study. The bubbles have four different sizes, representing four different study size categories:
!100 participants; 100e500 participants; 500e1,000 participants; and O1,000 participants. The reviews are sorted by mean prevalence.
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for both approaches was similar.
Predictive values are assumed to be directly influenced
by variation in prevalence. Fig. 3 shows the summary esti-
mates of the predictive values alongside the median and
range of prevalence within each review. Across reviews,
there is a trend toward a higher PPVand a lower NPVas me-
dian prevalence increases. We tested for a relationship be-
tween prevalence and predictive values within reviews by
adding covariate terms for prevalence in the predictive-
value bivariate model, with separate terms for its impact
on PPV and NPV. Significant relationships (P! 0.05) were
detected within most reviews, with only six reviews not
demonstrating significant relationships for either PPV or
NPV (results not shown). For example, the meta-analysis
of 17 studies of ultrasound for peripheral arterial stenosis
[35] reported a broad range in prevalence (5e72%) but a nar-
row range in predictive values. PPV ranged from 0.65 to
0.99 and showed no significant relationship with prevalence
(P5 0.40); NPV ranged from 0.66 to 0.98 and the effect of
prevalence was significant (P! 0.001).
3.4. Comparison of meta-analysis of predictive values
vs. estimates derived from meta-analysis of sensitivity
and specificity
The absolute difference between directly estimated pre-
dictive values and those projected after pooling sensitivityand specificity and using the median prevalence varied be-
tween 0% points and 10% points (median 1% point, IQR
0e2% points) (see Fig. 3). One review showed a difference
of 10% points for both PPV and for NPV: the directly esti-
mated PPV was 10% higher and the directly estimated NPV
was 10% points lower than the predictive value estimated
after estimating sensitivity and specificity [28]. This review
also showed the broadest range in prevalence among the in-
cluded studies (range 17e95%). In one other review, these
differences were 6% points and 9% points, respectively
[16]. This review showed a moderate range in prevalence
(from 56% to 98%).4. Discussion
In this article, we have proposed an approach for the
meta-analysis of NPVand PPV. Our strategy relies on a log-
itnormal bivariate random-effects model, similar to the one
previously proposed for meta-analysis of sensitivity and
specificity. In a series of existing systematic reviews, the
model converged in all included meta-analyses. There
was no systematic difference in the goodness of fit between
the random-effects models based on predictive values and
the conventional one, based on sensitivity and specificity,
for the same data. In most meta-analyses, sensitivity and
specificity did show less variation than predictive values,
but this difference was not significant. There were no
Fig. 3. Positive predictive value (PPV), negative predictive value (NPV), and prevalence together with their corresponding 95% confidence intervals.
PPV and NPV are either directly calculated (blue closed diamonds) or calculated from the estimates for sensitivity and specificity (open diamonds).
The right-hand graph shows the accompanying median (closed squares) and range for prevalence in each meta-analysis. The reviews are sorted by
mean prevalence.
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estimates of predictive values and those calculated through
Bayes’ rule from summary estimates of sensitivity and
specificity.
A number of potential limitations to our comparison
have to be taken into account. One of the reasons that we
did not find statistically significant differences between
pooling sensitivity and specificity and pooling predictive
values may be the relatively low number of studies per
meta-analyses. The number of studies varied between
10 and 39, so analyses may have been underpowered to
detect such differences. We also followed the judgments
of the review authors that the studies they included in each
meta-analysis were homogeneous enough to combine. Hadstricter criteria been used in terms of only combining stud-
ies with similar diagnostic thresholds and similar disease
prevalence heterogeneity may have been reduced in both
sets of analyses. Another limitation is related to the diffi-
culty in expressing heterogeneity in two dimensions. There
is no clear guidance on how heterogeneity in meta-analyses
of diagnostic accuracy should be measured and expressed.
Here, we proposed measuring the area of the prediction
ellipse as an overall measure of heterogeneity in two
directions.
There is no a priori statistical justification for selecting
a model for predictive values over a model for sensitivity
and specificity. Yet, in itself, meta-analysis of predictive
values has some advantages. Clinicians often tend to think
Fig. 4. Ratio between surface area of the prediction ellipses for the sens/spec approach and the positive predictive value (PPV)/negative predictive
value (NPV) approach. Sensitivity and specificity showed more heterogeneity in eight meta-analyses (light gray columns); PPV and NPV showed
more heterogeneity in 14 meta-analyses (dark gray columns); and in one meta-analysis both prediction ellipses had an equal area. The reviews
are sorted by mean prevalence.
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theoretical evidence exists that sensitivity and specificity
vary frequently from setting to setting, so it might be just
as practical and reasonable to perform meta-analysis of pre-
dictive values rather than sensitivity and specificity.
Another advantage of meta-analysis of predictive values
is that it provides researchers with valid estimates even
when those for sensitivity and specificity may be biased be-
cause of differential verification, or when meta-analysis of
these measures is simply impossible. This may be the case,
for example, in colonoscopy studies where negative find-
ings cannot be verified, or in cancer studies in which
biopsy is the reference standard: if the tumor is not found,
biopsy cannot be done. So none or only a small part of the
index test negatives will be verified. When estimating sen-
sitivity and specificity in such studies, there will be less
false negatives and true negatives (partial verification bias)
and the sensitivity will be inflated while the specificity will
be underestimated [5,9,37]. A solution for this may be to
use a different reference standard to verify the test nega-
tives, but this may lead to differential verification bias (of
which the effect is difficult to predict). Estimates of PPV
will not suffer from verification bias, as the test positives
are correctly verified. Only the NPV will be affected, but
not in the same way as sensitivity and specificity.
Meta-analysis of predictive values also has some potential
disadvantages. The effects of sources of heterogeneitydin
terms of bias and variationeare well documented for sensi-
tivity and specificity but have not been investigated as well
for their effect on predictive values. For example, the major
source of variation in sensitivity and specificity is related to
threshold differences for test positivity. When a higher test
value corresponds to a higher probability of disease, then in-
creasing the threshold will result in a lower sensitivity and
a higher specificity. Although this effect can also be seen in
predictivevalues, the effect of prevalence can bemuch larger.
Small changes in prevalence then overtake the changescaused by threshold effects. Another disadvantage is a minor
but very practical one: in our data set the models for predic-
tive values took a bit more effort to converge than the models
for sensitivity and specificity. It wasmore often needed to ad-
just starting values for parameters (although this can be
automated).
The main disadvantage of meta-analysis of predictive
values could be the interpretation of the results and the
translation into practice. Although sensitivity and specific-
ity are correlated with changes in positivity threshold, PPV
and NPV correlate, depending on changes in prevalence.
Furthermore, these models are all random-effects models
and assume that the true parameters of the outcome are
not constant but follow a normal distribution. When a re-
view contains studies using a broad range of different
thresholds, current guidance indicates that these studies
should not be analyzed using the bivariate method, but
rather with a hierarchical summary ROC method [2]. The
latter provides an overall estimate of the receiver operating
characteristic (ROC) curve, expressing dependence of accu-
racy on positivity threshold. This may be more appropriate
in such a case than providing pooled estimates of sensitivity
and specificity at an ‘‘average’’ threshold. A similar prob-
lem can occur when analyzing predictive values. When a re-
view contains studies with a broad range of prevalence,
there will be difficulties in working out how the average
predictive values (estimated for the average included study
with an average prevalence) can be applied in clinical prac-
tice. However, a broad range in prevalence should urge re-
searchers to investigate whether these difference may be
caused by differences in populations and settings, disregard
whether the outcome measure is sensitivity and specificity
or PPV and NPV.
Recently, a trivariate model has been proposed for meta-
analysis of predictive values and prevalence jointly, result-
ing in summary estimates of PPV, NPV, and prevalence
while taking into account the correlation between the three
1095M.M.G. Leeflang et al. / Journal of Clinical Epidemiology 65 (2012) 1088e1097measures [38]. This may, however, not solve the problems
outlined above, as it does not provide a structure for PPV
and NPV to vary with prevalence. A solution may be to al-
ways include prevalence as a covariate to the models when
analyzing predictive values and to report summary esti-
mates for, for example, the first quartile prevalence, the me-
dian prevalence, and the third quartile prevalence, as
presented in the included studies. This way, clinicians can
choose the prevalence, which they think corresponds best
with their particular situation, which would be a major
strength of this approach.
In this article, we did not explore using predictive value
models for comparing tests, nor did we investigate includ-
ing covariates for clinical subgroups in any of the models.
Such covariates are often used in explorations of heteroge-
neity, when meta-regression is applied to explore the sour-
ces of variability related to differences in study design and
execution, or to differences in patient groups and testing.
These covariates will have a very different meaning when
applied in a model for the meta-analysis of predictive
values than when applied to sensitivity and specificity. In
models comparing multiple tests, differences in disease
prevalence between tests or subgroups will hamper the in-
terpretation of observed differences in PPV and NPV. An
example would be if all studies of Test A are at a higher
prevalence than those of Test B. Evaluations of tests at
the same prevalence and clinical setting will be needed to
draw clinically robust conclusions as to which test performs
best in which situations [39]. An improved understanding
of the different effects of sources of heterogeneity and
the pros and cons of both approaches is required. Awaiting
this, researchers may consider reporting the results from
both models, including appropriate covariates.
In nearly all systematic reviews of medical tests, there is
a complex interplay between sensitivity, specificity, preva-
lence, and predictive values within and between studies,
something which review authors have to address carefully.
We have proposed a model for meta-analysis of predictive
values and applied it successfully to a range of previously
published systematic reviews of test accuracy studies.
Across the included systematic reviews, we found no signs
of a lower goodness of fit for this model compared with
a similar model for meta-analysis of sensitivity and speci-
ficity from the same data, in the absence of covariates. In
our view, the choice between the two models should rely
on the design of the original accuracy studies, the purpose
of the review and the questions guiding it, and on the het-
erogeneity between studies.Acknowledgments
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SAS syntax
Bivariate meta-analysis of sensitivity and specificity
data nl_test;
set _meta;
_recþ1;
_dis51; _nondis50; _pos5tpor; _n5tporþfnor; output;
_dis50; _nondis51; _pos5tnor; _n5fporþtnor; output;
label _pos5’no. correct classified’;
label _n5’Total’;
run;
ods output parameterestimates5est covmatparmest5
covmean;
proc nlmixed data5nl_test cov; *corr;
title ‘‘Bivariate analysis of sens and spec using
NLMIXED; &meta’’;
parms _sens51 _spec51 s2usens50.1 s2uspec50.5
covsesp50;
logitp5 (_sensþusens)*_disþ (_specþuspec)*_nondis;
p5exp(logitp)/(1þexp(logitp));
model _pos|binomial(_n,p);
random usens uspec|normal([0, 0], [s2usens,covsesp,
s2uspec]) subject5IDOR;
run;
ods output close;
Bivariate meta-analysis of predictive values
data nl_pvtest;
set _meta;
_recþ1
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output;
_testpos50; _testneg51; _pos5tnor; _n5fnorþtnor;
output;
label _pos5‘no. correct classified’;
label _n5‘Total’;
run;
ods output parameterestimates5pvest covmatparmest
5pvcovmean;
proc nlmixed data5nl_pvtest df51000 cov; *corr;
title ‘‘Bivariate analysis of ppv and npv using
NLMIXED &meta’’;
parms _ppv51 _npv52 s2uppv51 s2unpv50.5
covppvnpv50.5;
logitp 5 (_ppvþuppv)*_testposþ(_npvþunpv)
*_testneg;
p5exp(logitp)/(1þexp(logitp));
model _pos|binomial(_n,p);
random uppv unpv|normal([0, 0], [s2up-
pv,covppvnpv,s2unpv]) subject5IDOR;
run;
ods output close;References
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